• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淀粉样蛋白β 42/38 比值作为认知正常的老年人群早期记忆障碍的血浆生物标志物。

The amyloid beta 42/38 ratio as a plasma biomarker of early memory deficits in cognitively unimpaired older adults.

机构信息

Department of Neurobiology and Behavior, University of California Irvine, Irvine, CA, USA; Institute for Interdisciplinary Salivary Bioscience Research, University of California Irvine, Irvine, CA, USA.

Department of Neurobiology and Behavior, University of California Irvine, Irvine, CA, USA; Center for the Neurobiology of Learning and Memory, University of California, Irvine, Irvine, CA, USA.

出版信息

Neurobiol Aging. 2024 Dec;144:12-18. doi: 10.1016/j.neurobiolaging.2024.08.009. Epub 2024 Sep 3.

DOI:10.1016/j.neurobiolaging.2024.08.009
PMID:39241563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11706698/
Abstract

The amyloid beta (Aβ) 42/40 ratio has been widely studied as a biomarker in Alzheimer's disease (AD); however, other Aβ peptides could also represent relevant biomarkers. We measured levels of Aβ38/40/42 in plasma samples from cognitively-unimpaired older adults and determined the relationships between Aβ levels and amyloid positron-emission-tomography (PET) and performance on a learning and memory task. We found that all Aβ peptides individually and the Aβ42/40 ratio, but not the Aβ42/38 ratio, were significantly correlated with brain amyloid (Aβ-PET). Multiple linear modeling, adjusting for age, sex, education, APOE4 and Aβ-PET showed significant associations between the Aβ42/38 ratio and memory. Further, associations between the Aβ42/38 ratio and learning scores were stronger in males and in Aβ-PET-negative individuals. In contrast, no significant associations were detected between the Aβ42/40 ratio and any learning measure. These studies implicate the Aβ42/38 ratio as a biomarker to assess early memory deficits and underscore the utility of the Aβ38 fragment as an important biomarker in the AD field.

摘要

β 淀粉样蛋白 (Aβ) 42/40 比值已被广泛研究作为阿尔茨海默病 (AD) 的生物标志物;然而,其他 Aβ 肽也可能代表相关的生物标志物。我们测量了认知正常的老年人血浆样本中的 Aβ38/40/42 水平,并确定了 Aβ 水平与淀粉样蛋白正电子发射断层扫描 (PET) 和学习记忆任务表现之间的关系。我们发现,所有 Aβ 肽个体以及 Aβ42/40 比值,但不是 Aβ42/38 比值,与脑淀粉样蛋白 (Aβ-PET) 显著相关。多元线性模型,调整年龄、性别、教育、APOE4 和 Aβ-PET 后,Aβ42/38 比值与记忆之间存在显著关联。此外,Aβ42/38 比值与学习分数之间的关联在男性和 Aβ-PET 阴性个体中更强。相比之下,Aβ42/40 比值与任何学习测量均无显著关联。这些研究表明 Aβ42/38 比值可作为评估早期记忆缺陷的生物标志物,并强调 Aβ38 片段作为 AD 领域重要生物标志物的效用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13eb/11706698/090cdf3982fb/nihms-2041126-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13eb/11706698/664e523f99e1/nihms-2041126-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13eb/11706698/090cdf3982fb/nihms-2041126-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13eb/11706698/664e523f99e1/nihms-2041126-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13eb/11706698/090cdf3982fb/nihms-2041126-f0002.jpg

相似文献

1
The amyloid beta 42/38 ratio as a plasma biomarker of early memory deficits in cognitively unimpaired older adults.淀粉样蛋白β 42/38 比值作为认知正常的老年人群早期记忆障碍的血浆生物标志物。
Neurobiol Aging. 2024 Dec;144:12-18. doi: 10.1016/j.neurobiolaging.2024.08.009. Epub 2024 Sep 3.
2
Salivary levels of amyloid beta reflect brain amyloid beta burden in cognitively-normal older adults.认知功能正常的老年人唾液中β-淀粉样蛋白水平反映脑内β-淀粉样蛋白负荷。
J Prev Alzheimers Dis. 2025 Jun 9:100216. doi: 10.1016/j.tjpad.2025.100216.
3
The impact of kidney function on Alzheimer's disease blood biomarkers: implications for predicting amyloid-β positivity.肾功能对阿尔茨海默病血液生物标志物的影响:对预测淀粉样蛋白-β阳性的意义。
Alzheimers Res Ther. 2025 Feb 19;17(1):48. doi: 10.1186/s13195-025-01692-z.
4
Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer's disease spectrum.血浆磷酸化tau217与阿尔茨海默病谱系中的记忆缺陷密切相关。
Brain. 2025 Jan 29. doi: 10.1093/brain/awaf033.
5
Comparative performance of plasma pTau181/Aβ42, pTau217/Aβ42 ratios, and individual measurements in detecting brain amyloidosis.血浆pTau181/Aβ42、pTau217/Aβ42比值及个体测量值在检测脑淀粉样变性中的比较性能
EBioMedicine. 2025 Jun 12;117:105805. doi: 10.1016/j.ebiom.2025.105805.
6
Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment.血浆磷酸化 tau 217 和 Aβ42/40 预测认知正常人群的早期脑 Aβ 蓄积。
JAMA Neurol. 2024 Sep 1;81(9):947-957. doi: 10.1001/jamaneurol.2024.2619.
7
Plasma phosphorylated tau 217 and amyloid‑β 42/40 for amyloid risk in subgroups.血浆磷酸化tau 217和淀粉样蛋白β 42/40用于亚组中的淀粉样蛋白风险评估
Alzheimers Res Ther. 2025 Aug 7;17(1):184. doi: 10.1186/s13195-025-01826-3.
8
Profiling Plasma Biomarkers, Particularly pTau217 and pTau217/Aβ42, and Their Relation to Cognition in Memory Clinic Patients.分析记忆门诊患者的血浆生物标志物,特别是pTau217和pTau217/Aβ42,及其与认知的关系。
J Neurochem. 2025 Aug;169(8):e70182. doi: 10.1111/jnc.70182.
9
The associations between nutritional status and physical frailty and Alzheimer's disease plasma biomarkers in older cognitively unimpaired adults with positive of amyloid-β PET.在有淀粉样蛋白-β PET 阳性的认知正常老年人中,营养状况与身体虚弱和阿尔茨海默病血浆生物标志物之间的关联。
Clin Nutr. 2024 Jul;43(7):1647-1656. doi: 10.1016/j.clnu.2024.05.024. Epub 2024 May 16.
10
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.

引用本文的文献

1
Associations between digital speech features of automated cognitive tasks and trajectories of brain atrophy and cognitive decline in early Alzheimer's disease.早期阿尔茨海默病中自动化认知任务的数字语音特征与脑萎缩轨迹及认知衰退之间的关联。
J Alzheimers Dis. 2025 Sep;107(1):154-169. doi: 10.1177/13872877251359967. Epub 2025 Jul 20.
2
Salivary levels of amyloid beta reflect brain amyloid beta burden in cognitively-normal older adults.认知功能正常的老年人唾液中β-淀粉样蛋白水平反映脑内β-淀粉样蛋白负荷。
J Prev Alzheimers Dis. 2025 Jun 9:100216. doi: 10.1016/j.tjpad.2025.100216.
3
Linking higher amyloid beta 1-38 (Aβ(1-38)) levels to reduced Alzheimer's disease progression risk.

本文引用的文献

1
Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.阿尔茨海默病连续体中的血浆 Aβ42/40 比值、p-tau181、GFAP 和 NfL:AIBL 队列的横断面和纵向研究。
Alzheimers Dement. 2023 Apr;19(4):1117-1134. doi: 10.1002/alz.12724. Epub 2022 Jul 21.
2
Entorhinal-Hippocampal Circuit Integrity Is Related to Mnemonic Discrimination and Amyloid-β Pathology in Older Adults.内嗅皮层-海马环路完整性与老年人的记忆辨别和淀粉样β病理学相关。
J Neurosci. 2022 Nov 16;42(46):8742-8753. doi: 10.1523/JNEUROSCI.1165-22.2022. Epub 2022 Oct 27.
3
将较高的β淀粉样蛋白1-38(Aβ(1-38))水平与降低的阿尔茨海默病进展风险联系起来。
Alzheimers Dement. 2025 Feb;21(2):e14545. doi: 10.1002/alz.14545. Epub 2025 Jan 27.
Amyloid-β peptide 37, 38 and 40 individually and cooperatively inhibit amyloid-β 42 aggregation.
淀粉样β肽37、38和40分别及协同抑制淀粉样β42聚集。
Chem Sci. 2022 Feb 7;13(8):2423-2439. doi: 10.1039/d1sc02990h. eCollection 2022 Feb 23.
4
Association of CSF Aβ Levels With Risk of Alzheimer Disease-Related Decline.脑脊液 Aβ 水平与阿尔茨海默病相关衰退风险的关联。
Neurology. 2022 Mar 1;98(9):e958-e967. doi: 10.1212/WNL.0000000000013228. Epub 2021 Dec 22.
5
Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease.阿尔茨海默病中 8 种血浆淀粉样蛋白β 42/40 分析物的对头比较。
JAMA Neurol. 2021 Nov 1;78(11):1375-1382. doi: 10.1001/jamaneurol.2021.3180.
6
Quantitative Measurement of Cerebrospinal Fluid Amyloid-β Species by Mass Spectrometry.采用质谱法对脑脊髓液淀粉样蛋白-β 进行定量测量。
J Alzheimers Dis. 2021;79(2):573-584. doi: 10.3233/JAD-200987.
7
Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays.临床前队列中阿尔茨海默病病理学脑脊液指标与淀粉样蛋白PET状态的一致性:Lumipulse与既定免疫测定法的比较
Alzheimers Dement (Amst). 2020 Sep 13;12(1):e12097. doi: 10.1002/dad2.12097. eCollection 2020.
8
Longitudinal evaluation of the natural history of amyloid-β in plasma and brain.血浆和大脑中β淀粉样蛋白自然史的纵向评估。
Brain Commun. 2020 Apr 14;2(1):fcaa041. doi: 10.1093/braincomms/fcaa041. eCollection 2020.
9
Emerging roles of N- and C-terminally truncated Aβ species in Alzheimer's disease.N- 和 C- 端截断的 Aβ 种在阿尔茨海默病中的新兴作用。
Expert Opin Ther Targets. 2019 Dec;23(12):991-1004. doi: 10.1080/14728222.2019.1702972. Epub 2019 Dec 12.
10
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis.高精度血浆β-淀粉样蛋白 42/40 可预测当前和未来的脑淀粉样变。
Neurology. 2019 Oct 22;93(17):e1647-e1659. doi: 10.1212/WNL.0000000000008081. Epub 2019 Aug 1.